Gentianella amarella

Gentianella amarella (Autumn Gentian / Felwort): A Comprehensive Reference

1. Identity: Botanical Classification, Nomenclature, and Plant Description

Gentianella amarella (L.) Börner is a flowering plant in the family Gentianaceae, order Gentianales, class Magnoliopsida, division Tracheophyta. Its full taxonomic hierarchy places it within Kingdom Plantae, Division Tracheophyta, Class Magnoliopsida, Order Gentianales, and Family Gentianaceae. The species is commonly known in English as the autumn gentian, autumn dwarf gentian, or autumn felwort.

The genus name Gentianella is a diminutive of "Gentian," a name in Pliny for a plant named after Gentius, a 2nd-century Illyrian king reputed to have discovered the medicinal use of Gentiana lutea. The species epithet amarella is the feminine diminutive of the Latin amarus, meaning "bitter." Old English names for these gentians — Bitterwort and Felwort (fel being an old word for gall) — further testify to their bitter qualities being popularly known.

Gentianella amarella is a biennial herbaceous plant that produces only a low leaf rosette with elliptical to lanceolate leaves in its first year. In the second year it usually grows a stem from 5 to 30 (occasionally 3 to 50) centimeters long; the stem is straight or branched just above the base and, at flowering time, is without leaves, which distinguishes it from similar species. It is a biennial growing to 0.3 m, flowering from August to September, with seeds ripening from September to October; the species is hermaphrodite and pollinated by bees.

There are about five subspecies; its habitat is grass, often on lime-rich soil (in England typically on chalk), and it grows on dry, sandy or calcareous soils, but also on wet peat or marl soils, thriving in bog meadows.

1.1 Synonymy and Historical Nomenclature

The species was originally described by Linnaeus under the basionym Gentiana amarella L. and was subsequently reclassified into the segregate genus Gentianella by Börner. A key subspecies with particular relevance to phytochemical and pharmacological research is Gentianella amarella ssp. acuta, which carries the synonym Gentiana acuta Michx. and is also treated as a separate species, Gentianella acuta (Michx.) Hultén, by some authorities. Plants of the genus Gentianella (Gentianaceae), comprising about 250 species of which many have a bitter taste, are distributed in temperate regions throughout the world. Gentianella amarella ssp. acuta (synonym Gentiana acuta) is an annual herb distributed in East Asia, Siberia, and North America.

1.2 Geographic Distribution and Habitat

The native range of Gentianella amarella subsp. amarella spans Europe to western and southern Siberia and Central Asia. It is an annual or biennial growing primarily in the temperate biome. Recorded countries of occurrence include Austria, Belgium, Bulgaria, Denmark, Finland, France, Germany, Great Britain, Hungary, Italy, Kazakhstan, Norway, Poland, Romania, Sweden, Switzerland, Ukraine, and regions of Russia including Buryatiya, Krasnoyarsk, and West Siberia, among others.

Gentianella amarella, the autumn gentian, is found throughout Northern Europe, the western and northern United States, and Canada. Within Great Britain, it has declined since the 1960s, mainly in lowland regions on the edges of its core range due to loss of habitat through agricultural intensification and lack of management; it remains locally common in its strongholds in chalk and limestone grassland in southern and northern Britain.

British populations are genetically very variable, and recent taxonomic revisions now recognize four subspecies in the region; the most widespread is subsp. amarella, which now incorporates the formerly recognized subsp. hibernica. The other three subspecies are subsp. anglica, subsp. occidentalis, and a fourth. Subsp. anglica (Pugsley) T.C.G.Rich & McVeigh, first published in 2018, is native to Great Britain (East Central and South England) and is a biennial growing primarily in the temperate biome.

1.3 Common Preparations and Dosage Forms

Historically and in modern herbal practice, the plant has been utilized in several forms:

• Dried root and aerial parts: The root is harvested in the autumn and dried for later use; it is considered likely that the roots of plants that have not yet flowered are the richest in medicinal properties.
• Tincture (liquid extract): A hydroethanolic extract prepared from dried roots or the whole plant, used orally as a digestive bitter.
• Infusion/decoction: Hot-water preparations of the aerial parts or root for internal use in traditional settings.
• Bach Flower Remedy: The plant is used in Bach flower remedies — the keywords for prescribing it are "Doubt," "Depression," and "Discouragement." In the Bach flower system, the liquid mother tincture is filtered and mixed with brandy as a preservative; remedies can be taken orally diluted in a glass of water, or applied directly to pulse points.
• Cosmetic flower extract: Gentianella amarella flower extract is derived from the flowers of the plant; the extract is rich in compounds such as flavonoids, iridoids, and secoiridoids, believed to contribute to skin-conditioning properties.

---

2. Traditional and Historical Use

2.1 European Tradition

Like related members of the Gentianaceae, G. amarella has been substituted in Britain and Ireland at times for the more famous Yellow Gentian (Gentiana lutea) in herbal medicine as a tonic, to cleanse the blood and kidneys, and for indigestion and colic, jaundice, wounds, sores, and rheumatism. The English common name "Felwort" originally referred to the important imported medicinal herb Gentiana lutea, but the name became transferred to the related native herb with similar medicinal properties.

The two most frequently found native gentians are Gentiana amarella (the Autumn Gentian) and G. campestris (the Field Gentian), which were formerly considered by both Linnaeus and Scopoli to be merely variations of the same species. Both have been used for their bitterness instead of hops, and also as medicine; the dried root and dried herb of the Field Gentian are still sold by herbalists for use as a bitter tonic, having the same properties as the foreign Gentian.

In European herbal tradition, the plant is described as especially useful in states of exhaustion from chronic disease and in all cases of debility, weakness of the digestive system, and lack of appetite. It is considered one of the best strengtheners of the human system and an excellent tonic to combine with a purgative in order to prevent debilitating effects. Attributed traditional properties of the root include anthelmintic, anti-inflammatory, antiseptic, bitter tonic, cholagogue, emmenagogue, febrifuge, refrigerant, and stomachic.

2.2 Mongolian and Central/East Asian Tradition

Gentianella amarella is known in the traditional medicine of Mongolia to cure headache, hepatitis, fever, and gallbladder disorders. More specifically, research based on ethnopharmacological field studies confirms that Gentianella amarella ssp. acuta has been used as a traditional herbal medicine for the treatment of headache, fever, hepatitis, and gallbladder disorders in Mongolia.

Gentianella acuta is a traditional remedy for cardiovascular ailments among the Ewenki people of China and has been reported to contain xanthones as its primary bioactive components. The Elunchun people have been using G. acuta to treat arrhythmias and other heart diseases for thousands of years. Gentianella acuta was reported in previous studies to contain xanthones, iridoids, terpenoids, and sterols, and is mainly used to cure hepatitis, jaundice, fever, headache, and angina pectoris.

2.3 Tibetan Medical Tradition

Species from the Gentianeae are widely used in traditional Tibetan medicine, with botanical, ethnomedicinal, phytochemical, and pharmacological properties well-documented in systematic reviews. Approximately 83 species from Gentianeae were used in Tibetan medicine. The species are mainly used as Bangjian, Jieji, Dida, and Ganggaqiong in Tibetan medicine with different clinical applications. More than 240 formulas were found containing Gentianeae species with different attending functions.

2.4 South American Folk Tradition

In South America, Gentianella species have been used as traditional remedies for the treatment of digestive and liver problems. Five Argentine Gentianella species — G. florida, G. multicaulis, G. riojae, and G. parviflora — locally known as "nencia," "pasto amargo" (bitter grass), or "genciana," are used in folkloric medicine, with studies conducted on their chemical content and some pharmacological activities. Traditional uses include the treatment of digestive disorders and use as stimulants for appetite; specifically, G. florida and G. multicaulis have histories as appetite stimulants and bitter tonics.

2.5 Bach Flower Remedy Context

Bach flower remedies are a widely available, popular form of complementary and alternative medicine developed in the 1930s by the British physician Dr. Edward Bach. Bach devoted his life to the discovery of 38 remedies that correspond to 38 negative emotional states. The Bach flower remedy known as Gentian is derived from Gentiana amarella (Gentianella amarella), a plant in the same botanical family that grows in mountain pastures and features blue-purple flowers. Flower therapy falls under alternative medicine, and its principles are not based on traditional evidence-based science. In the Bach flower system, Gentian is recommended for individuals who discourage easily in the face of obstacles or exhibit a lack of self-confidence.

---

3. Key Constituents and Active Compounds

Like other species of the Gentianaceae family, Gentianella plants are characterized by the universal occurrence of three main groups of secondary metabolites: iridoids, flavonoids, and xanthones. The specific phytochemical profile of G. amarella and its subspecies has been progressively elucidated through laboratory investigations.

3.1 Secoiridoid Glycosides (Bitter Principles)

Bitter principles — secoiridoid glycosides — and xanthones are widely distributed among plants belonging to the family Gentianaceae. The principal secoiridoid in the genus is gentiopicroside (also called gentiopicrin), along with swertiamarin, sweroside, and amarogentin. Among the secoiridoids, gentiopicroside, amarogentin, and swertiamarin are both the most abundant (collectively 1–6% of G. lutea root dry weight in the congener species) and the most frequently investigated, underpinning the family's well-documented hepatoprotective and anti-inflammatory actions. These compounds are responsible for the characteristic extreme bitterness of the plant; the most characteristic aspect of gentian is its bitter taste imparted by a number of iridoid glycosides, primarily amarogentin, gentiopicrin (about 1.5% in fresh roots), gentiopicroside, and swertiamarin.

3.2 Xanthones

Xanthones are a structurally distinctive class of oxygenated heterocyclic compounds especially prominent in G. amarella ssp. acuta. Xanthone compounds typical of Gentianella species belong to the bellidifolin type of xanthones, which mostly occur in the form of O-glycosides, and are responsible for a wide range of therapeutic properties attributed to Gentianella plants.

A 2008 study published in the Journal of Natural Products by Urbain et al. conducted a targeted phytochemical isolation from G. amarella ssp. acuta. Two new xanthone glycosides — corymbiferin 3-O-β-D-glucopyranoside and swertiabisxanthone-I 8′-O-β-D-glucopyranoside — were isolated from Gentianella amarella ssp. acuta, along with eight known xanthones: triptexanthoside C, veratriloside, corymbiferin 1-O-glucoside, swertianolin, norswertianolin, swertiabisxanthone-I, bellidin, and bellidifolin, four of them identified for the first time in G. amarella ssp. acuta. The isolation was conducted mainly by centrifugal partition chromatography, with structures established by 2D NMR and mass spectrometry.

A subsequent UPLC-Q/TOF-MS/MS analysis of the total xanthone fraction from G. acuta revealed a broader profile: 29 constituents were identified in total xanthone extracts, including xanthones, flavonoids, lignans, iridoids, and coumarins. Key individual xanthones identified include swertianolin, norswertianolin, bellidifolin, demethylbellidifolin, and mangiferin.

The aerial parts of Gentianella species concentrate flavonoids, with isoorientin and isovitexin occurring prominently in studies on melanogenesis inhibition and vascular protection. Although present at lower levels, the xanthones bellidifolin and isogentisin are the focus of a growing body of neuroprotective and antioxidant research.

3.3 Novel Tetrahydroxanthones (Amarellins)

A particularly notable phytochemical finding specific to G. amarella ssp. acuta was reported from Mongolian plant material. The phytochemical investigation of the aerial parts of G. amarella ssp. acuta yielded two tetrahydroxanthones — 1,3,5S,8S-tetrahydroxy-5,6,7,8-tetrahydroxanthone and 1,3,5R,8S-tetrahydroxy-5,6,7,8-tetrahydroxanthone — and six new tetrahydroxanthone glycosides, designated amarellins A–F. The structures of amarellins 1–8 were elucidated on the basis of spectroscopic analysis, chemical conversion, and ECD calculation; amarellins A–C were assigned as 8-O-β-D-glucoside, 8-O-β-D-xyloside, and 1-O-β-D-glucoside of the first aglycone, respectively.

3.4 Flavonoids and C-Glycosylflavonoids

Secoiridoids, xanthones, C-glycosylflavonoids, and triterpenic acids have been identified across multiple Gentianella species. The occurrence of mangiferin together with the flavone-C-glucosides isoorientin and swertisin is most common and typical for Gentianella species.

3.5 Triterpenoids

Hepatoprotective properties among Gentianella compounds have been attributed to oleanolic and ursolic acids, which were shown to protect against liver injury in laboratory animals.

---

4. Mechanisms of Action

4.1 Bitter Receptor Activation and Digestive Secretion

The secoiridoid glycosides, most prominently gentiopicroside and amarogentin, produce intense bitterness that activates bitter taste receptors (TAS2Rs) in the oral cavity and gastrointestinal tract. Bitter tastants act directly on the mucosa of the upper part of the gastrointestinal tract and especially on the bitter receptors to release saliva and gastric juices; this hypothesis is supported by recent studies demonstrating that bitter, sour, sweet, and umami taste receptor cells are present in the stomach, duodenum, jejunum, ileum, and colon.

4.2 Anti-inflammatory Pathways

Gentiana/Gentianella extracts target NF-κB and MAPK pathways to suppress inflammation and oxidative liver injury via Nrf2 activation. In studies with G. acuta, aqueous extracts caused improvements in myocardial injury and fibrosis, inhibited collagens I and III and α-smooth muscle actin production in heart tissue, and downregulated TGF-β1 expression while notably inhibiting the phosphorylation of TGF-β receptors I and II.

In the context of acute myocardial injury, network pharmacology analysis, supported by qRT-PCR, molecular docking, and surface plasmon resonance experimental validation, revealed that total xanthone fraction anti-AMI effects are linked to modulation of inflammatory responses; key therapeutic targets identified include TLR4, NF-κB, and NLRP3, with in vivo and in vitro experiments confirming that the total xanthone fraction reduced BRD4 expression, thereby inhibiting TLR4/NF-κB/NLRP3 signaling, attenuating cardiomyocyte pyroptosis and inflammation, reducing infarct size, and improving functional and pathological outcomes.

4.3 Antioxidant and Cytoprotective Mechanisms (Nrf2 / HO-1 Pathway)

A 2019 cell-based study examined the specific xanthone constituents of G. acuta in a cardiac oxidative-stress model. All four tested compounds — norswertianolin, swertianolin, demethylbellidifolin, and bellidifolin — had protective effects on H9c2 cardiomyocyte cells exposed to hydrogen peroxide. The transcription levels of HO-1 (heme oxygenase-1) and GCLC (glutamate-cysteine ligase catalytic subunit) significantly increased in cells pretreated with these compounds; however, the transcription levels of Nrf2 itself were not enhanced by pretreatment with three of the four compounds.

4.4 Monoamine Oxidase and Acetylcholinesterase Inhibition

In the Urbain et al. study, xanthones were weakly active against acetylcholinesterase (AChE), except triptexanthoside C, which inhibited AChE with an IC₅₀ of 13.8 ± 1.6 µM. Regarding monoamine oxidases (MAO), bellidin and bellidifolin showed interesting inhibitory activity of MAO-A, while swertianolin (the 8-O-glucopyranoside form of bellidifolin) also demonstrated MAO inhibitory activity. In a separate study by the same authors, bellidifolin isolated from Gentianella amarella was characterized as a weak AChE inhibitor.

4.5 Glucose Regulation

Many compounds from Gentianeae, especially xanthones and iridoid derivatives, have been reported to have glucose-regulating effects; demethylbellidifolin can stimulate the GLP-1 receptor in a concentration-dependent manner and reduce blood glucose levels. Bellidifolin itself was observed to reduce blood glucose levels, indicating a hypoglycemic effect. An earlier preclinical study (Basnet et al., 1995, published in Planta Med.) demonstrated that bellidifolin stimulates glucose uptake in rat-1 fibroblasts and ameliorates hyperglycemia in streptozotocin-induced diabetic rats.

4.6 Intestinal Smooth Muscle Effects

Amarellins A–F, isolated from G. amarella ssp. acuta, were also evaluated for their inhibitory effects on isolated intestinal smooth muscle contractions. The bioactive substances of G. acuta have been revealed to exert a beneficial effect on aberrant intestinal motility.

4.7 Cardiac Remodelling Pathways

G. acuta effectively improves transverse aortic constriction (TAC)-induced cardiac function disorder and remodelling by alleviating myocardial fibrosis, inhibiting hypertrophy, reducing autophagy, blocking endothelial-to-mesenchymal transition (EndMT), and regulating the PI3K/Akt/FOXO1/3a and Notch signalling pathways. Current evidence suggests that G. acuta and its xanthone components exert cardioprotective effects both in vivo and in vitro through anti-inflammatory and antioxidant activities.

---

5. Scientific Evidence by Area of Use

Important note on evidence scope: Essentially all controlled experimental evidence for Gentianella amarella sensu lato derives from preclinical (in vitro cell culture and animal) models, largely using the subspecies acuta / Gentianella acuta. There are currently no published randomized controlled clinical trials (RCTs) in human populations that have specifically evaluated Gentianella amarella or its isolated xanthone constituents as primary interventions. The evidence base is therefore preliminary and exploratory. Extrapolation to human therapeutic use is not supported by clinical trial data at this time.

5.1 Cardiovascular Protection (Preclinical)

Area: Myocardial fibrosis, acute myocardial infarction, cardiac remodelling, hypercholesterolaemia.

Evidence level: Preclinical only (animal and cell models).

Gentianella acuta is one of the most commonly used herbs in Chinese Mongolian medicine for the treatment of heart disease. Earlier work demonstrated that it ameliorated cardiac function and inhibited isoproterenol-induced myocardial fibrosis in rats. A follow-up mechanistic study further found that the aqueous extract caused improvements in myocardial injury and fibrosis, inhibited collagens I and III and α-smooth muscle actin production in heart tissue, and downregulated TGF-β1 expression while inhibiting phosphorylation of TGF-β receptors I and II.

A 2025 study in Phytomedicine (ScienceDirect) investigated the total xanthone fraction (TXG) from G. acuta in acute myocardial infarction. The study demonstrated that xanthones — the major constituents of G. acuta — are absorbed into the bloodstream and exert their therapeutic effects by inhibiting pyroptosis-mediated cardiac inflammation. Xanthones such as bellidifolin and mangiferin have shown effectiveness in mitigating long-term post-myocardial infarction ventricular remodelling, including myocardial fibrosis and hypertrophy.

A 2021 PMC-published study examined the effects of G. acuta on diet-induced hypercholesterolaemia in rats. G. acuta ameliorated cardiac structural disorders, excessive collagenous fiber accumulation in the heart, and cardiac malfunction by regulating the NF-κB pathway in a model of myocardial fibrosis.

Limitations: All studies are animal or cell-based. No human clinical trial data exist. Translation of results to human cardiovascular disease is speculative without further clinical investigation.

5.2 Digestive Health and Bitter-Tonic Effects

Area: Appetite stimulation, gastric secretion, dyspepsia.

Evidence level: Traditional use well-documented; limited uncontrolled human evidence for the broader gentian class; no specific RCTs for G. amarella.

Gentian has a long history of use as a herbal bitter in the treatment of digestive disorders; it is described as especially useful in states of exhaustion from chronic disease and in all cases of debility, weakness of the digestive system, and lack of appetite. In two uncontrolled clinical studies using gentian extracts (not specific to G. amarella), stimulation of gastric secretions was increased and gastrointestinal symptoms (e.g., abdominal pain, constipation, dyspepsia, heartburn) were reduced.

Gentiana/Gentianella extracts have been shown preclinically to enhance gastrointestinal repair and regulate motility. These effects are attributed to the activation of bitter taste receptors by gentiopicroside and related secoiridoids, triggering a cephalic-phase reflex that increases saliva and gastric juice production.

Limitations: The two uncontrolled clinical studies cited are not specific to G. amarella and lack placebo controls, randomization, and adequate sample sizes. Robust human data for this specific species are absent.

5.3 Hepatoprotection

Area: Liver protection, hepatitis, jaundice.

Evidence level: Primarily preclinical and traditional; limited clinical evidence for gentiopicroside (not species-specific).

The biological results and the presence of the identified compounds in Gentianella species may justify the traditional uses as liver protective and bitter tonic agents. Hepatoprotective properties have been attributed to oleanolic and ursolic acids present in the species; these acids were shown to protect against liver injury in laboratory animals.

For the broader gentian class, clinically, gentiopicroside demonstrates hepatoprotective, antiviral, and neuroprotective effects, with applications in herpes zoster, non-alcoholic fatty liver disease, and metabolic disorders. However, this clinical evidence pertains to gentiopicroside as an isolated compound largely studied in Chinese clinical contexts using species such as Gentiana scabra, not to G. amarella preparations specifically.

Limitations: Hepatoprotective clinical evidence is not specific to G. amarella. Animal and in vitro findings cannot be directly extrapolated to clinical hepatological outcomes.

5.4 Anti-inflammatory and Analgesic Effects

Area: General inflammation, joint and articular inflammation.

Evidence level: Preclinical only.

Phytochemicals present in Gentianaceae species — including amarogentin, bellidifolin, gentianine, and swerchirin — have been reported to possess significant anti-inflammatory, analgesic, anti-asthmatic, anticonvulsant, antihistaminic, antimalarial, antiamoebic, cytoprotective, diuretic, hepatoprotective, and hypoglycemic properties in preclinical investigations. Extracts from related Gentianeae species were proved to alleviate adjuvant arthritis, synovial inflammation, and rheumatoid arthritis by affecting different targets and pathways; gentiopicroside and swertiamarin also played an important role in joint and bone protection through inactivation of JNK and NF-κB signalling pathways.

Limitations: All evidence is from animal models of inflammation or in vitro systems. No human clinical trials specifically address G. amarella or its isolated compounds for inflammatory conditions.

5.5 Glycaemic Regulation / Antidiabetic Effects

Area: Blood glucose regulation, insulin secretion/sensitivity.

Evidence level: Preclinical only.

Bellidifolin — a principal xanthone of Gentianella species — stimulates glucose uptake in rat-1 fibroblasts and ameliorates hyperglycemia in streptozotocin-induced diabetic rats (Basnet et al., 1995, Planta Med.). Demethylbellidifolin can stimulate the GLP-1 receptor in a concentration-dependent manner and reduce blood glucose levels.

Limitations: Evidence is restricted to cell and animal models. No human data exist for G. amarella extracts or its xanthone constituents in glycaemic regulation.

5.6 Neuroprotection

Area: Nerve injury protection, acetylcholinesterase inhibition.

Evidence level: Preclinical / in vitro only.

Bellidifolin is known for neuroprotective properties against ischemia and sciatic nerve injury. A study investigating the impact of pretreatment with bellidifolin on the severity of nerve injury caused by hypoxia showed a significant increase in the survival rate of pheochromocytoma cells (PC12). Regarding enzyme inhibition, xanthones from G. amarella ssp. acuta were generally weakly active against acetylcholinesterase, except triptexanthoside C, which inhibited AChE with an IC₅₀ of 13.8 ± 1.6 µM.

Limitations: All neuroprotection data are from cell-culture experiments (PC12 cells) or in vitro enzyme assays. No animal or human studies have assessed G. amarella preparations specifically for neurodegenerative disease endpoints.

5.7 Bach Flower Remedy Use for Psychological States

Evidence level: No clinical benefit demonstrated; probably safe.

A systematic review of Bach flower remedies (BFRs) published in PMC concluded that most of the available evidence regarding the efficacy and safety of BFRs has a high risk of bias. Based on reported adverse events in six trials, BFRs are probably safe. Few controlled prospective trials of BFRs for psychological problems and pain exist. Analysis of four controlled trials for examination anxiety and ADHD indicates that there is no evidence of benefit compared with a placebo intervention. Regarding the regulated product, this homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy, and the FDA is not aware of scientific evidence to support homeopathy as effective.

---

6. Body Systems and Health Areas Associated with Gentianella amarella

• Gastrointestinal system: Appetite stimulation, gastric acid and bile secretion, digestive tonic, relief of dyspepsia, colic, and indigestion. Bioactivities of Gentianeae plants include hepatic protection, upper respiratory tract protection, joint and bone protection, glucose regulation, antibacterial, antioxidant, anticancer, and antiviral effects.
• Hepatobiliary system: Traditionally used in jaundice and liver complaints; preclinical hepatoprotective evidence attributed to oleanolic/ursolic acids and gentiopicroside.
• Cardiovascular system: Preclinical evidence for myocardial anti-fibrotic, anti-inflammatory, and cardioprotective effects via xanthone constituents in the acuta subspecies.
• Endocrine/metabolic system: Preclinical hypoglycaemic evidence for bellidifolin and demethylbellidifolin via glucose uptake stimulation and GLP-1 receptor activation.
• Nervous system: Preclinical AChE inhibition (triptexanthoside C), MAO-A inhibition (bellidin, bellidifolin), and neuroprotection by bellidifolin in hypoxia models.
• Musculoskeletal/immune system: Preclinical anti-inflammatory effects attributed to iridoid glycosides and flavonoids.
• Skin: The flower extract is used in cosmetics; it is rich in flavonoids, iridoids, and secoiridoids, contributing to skin-conditioning properties; historically, the plant has been used in traditional medicine for purported anti-inflammatory benefits.

---

7. Dosage Forms and Reported Dosages

No published clinical trials have formally established dosage ranges specifically for Gentianella amarella preparations in human subjects. The following information reflects what appears in the scientific literature and traditional herbal practice records:

• Dried root/herb (traditional preparation): Used historically as a decoction or cold maceration; quantities are not standardized in the literature sourced. The root is harvested in autumn and dried for later use; roots of plants that have not flowered are considered likely to be the richest in medicinal properties.
• Gentian extract as a food bitter: Gentian extract is used as a bitter in concentrations of approximately 0.02% in non-alcoholic beverages.
• Research extract (preclinical): Studies on G. acuta extracts in animal models have used aqueous or ethanol extracts at doses defined for individual animal experiments (rat models), but these preclinical doses are not directly transferable to human use.
• Bach Flower Remedy: The mother tincture is filtered and mixed with brandy as a preservative; remedies can be taken orally diluted in a glass of water, or applied directly to pulse points such as the wrists, temples, and behind the ears. At these extreme dilutions, no phytochemically active dose of constituents is present.

---

8. Safety Considerations and Known Interactions

Safety data specific to Gentianella amarella as an isolated herbal preparation are limited in the peer-reviewed literature. Safety information available pertains primarily to the broader Gentianaceae class, particularly Gentiana lutea, with which G. amarella shares key phytochemical constituents including gentiopicroside and related secoiridoids.

8.1 Gastric and Gastrointestinal Effects

Gentian preparations are contraindicated in gastric or duodenal ulcers, as gentian can stimulate gastric acid secretion and pepsin release, aggravating ulcerative conditions. Preparations may cause hyperacidity and gastric distress; overdose may lead to nausea or vomiting.

8.2 Pregnancy and Lactation

Gentian preparations are not recommended during pregnancy, as they may have slight uterine stimulant properties. They are also not recommended during lactation. Emmenagogue action attributed to the root historically in European herbal tradition is consistent with this caution.

8.3 Potential Interaction with Antihypertensives

There is a theoretical risk that gentian may increase the risk of hypotension when combined with antihypertensive medication, but this has not been confirmed in clinical trials.

8.4 Bitter Glycoside Palatability and Concentration

The presence of somewhat toxic bitter glycoside substances in plant tissues does not greatly deter grazing animals. At high concentrations, excessive intake may cause stomach irritation, nausea, or headaches due to strong bitter properties; people with gastric ulcers or hyperacidity should use it cautiously as it can increase stomach acid production.

8.5 Regulatory Status of Bach Flower Remedy Formulation

The Bach flower remedy formulation containing Gentianella amarella is regulated in the United States as a homeopathic product. This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy; the FDA is not aware of scientific evidence to support homeopathy as effective.

8.6 Conservation Status — Foraging Caution

Gathering gentian root in the wild is strictly prohibited or heavily regulated by local laws because it is a protected species in many jurisdictions. In the UK, G. amarella has declined since the 1960s, mainly in lowland regions on the edges of its core range due to loss of habitat through agricultural intensification; it remains locally common only in its strongholds in chalk and limestone grassland.

---

9. Summary of Evidence Strength

The following table summarizes the current state of evidence for key areas associated with Gentianella amarella and its pharmacologically active subspecies and constituents:

• Digestive bitter/appetite stimulation: Strong traditional evidence across multiple cultures; supported by pharmacological rationale (bitter receptor activation); very limited uncontrolled human evidence; no specific RCTs.
• Hepatoprotection: Good preclinical (animal) evidence; clinical evidence for gentiopicroside (a shared constituent) in related species contexts only; no specific human trials for G. amarella.
• Cardioprotection (anti-fibrotic, anti-AMI): Growing preclinical evidence with mechanistic detail; entirely animal- and cell-based; no human data.
• Hypoglycaemic effects: Preclinical only (cell and animal models); no human clinical evidence.
• Neuroprotection / enzyme inhibition: In vitro data only; very preliminary.
• Bach flower remedy (psychological use): No demonstrated clinical benefit beyond placebo in controlled trials.

References

• Kadota S et al. Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies. PMC / J Nat Med. 2021.
• Urbain A, Marston A, Grilo LS, et al. Xanthones from Gentianella amarella ssp. acuta with acetylcholinesterase and monoamine oxidase inhibitory activities. J Nat Prod. 2008;71(5):895-897. PubMed.
• Urbain A et al. Xanthones from Gentianella amarella ssp. acuta with Acetylcholinesterase and Monoamine Oxidase Inhibitory Activities. Journal of Natural Products. ACS Publications.
• Gentianella lutescens subsp. carpatica: Shoot Propagation In Vitro and Effect of Sucrose and Elicitors on Xanthones Production. PMC. 2021.
• Tetrahydroxanthones from Mongolian medicinal plant Gentianella amarella ssp. acuta. Academia.edu.
• Bioactive compounds from Argentine Gentianella species. Academia.edu.
• A Review on the Ethnomedicinal Usage, Phytochemistry, and Pharmacological Properties of Gentianeae (Gentianaceae) in Tibetan Medicine. PMC. 2021.
• Gentianaceae Family—Derived Bioactive Compounds—Therapeutic Values and Supporting Role in Inflammation and Detoxification. PMC / Nutrients. 2025.
• Ren K et al. Effects of Four Compounds from Gentianella acuta on Hydrogen Peroxide-Induced Injury in H9c2 Cells. PMC / Evid Based Complement Alternat Med. 2019.
• Aqueous extract of Gentianella acuta improves isoproterenol-induced myocardial fibrosis via inhibition of the TGF-β1/Smads signaling pathway. PMC. 2019.
• The total xanthones from Gentianella acuta alleviate acute myocardial infarction by targeting BRD4-mediated cardiomyocyte pyroptosis and inflammation. Phytomedicine. ScienceDirect. 2025.
• Gentianella acuta improves TAC-induced cardiac remodelling by regulating the Notch and PI3K/Akt/FOXO1/3 pathways. Biomed Pharmacother. ScienceDirect. 2022.
• Gentianella acuta mitigates cardiovascular damage and inflammation in diet-induced hypercholesterolaemic rats. PMC. 2021.
• Gen-miR-5 derived from Gentianella acuta inhibits PFKP to prevent fibroblast activation and alleviate myocardial fibrosis. Frontiers in Pharmacology. 2025.
• Thaler K et al. Bach Flower Remedies for psychological problems and pain: a systematic review. BMC Complement Altern Med. PMC. 2009.
• Medicinal, biological and phytochemical properties of Gentiana species. PMC. 2017.
• The chemical structure, pharmacological activity, and clinical progress of Gentianae Radix et Rhizoma. Frontiers in Pharmacology / PMC. 2025.
• Phytochemicals of Gentianaceae: A review of pharmacological properties. ResearchGate.
• Gentianella amarella subsp. amarella. Plants of the World Online. Kew Science.
• Gentianella amarella subsp. anglica. Plants of the World Online. Kew Science.
• Gentianella amarella (L.) Börner, Autumn Gentian. Botanical Society of Britain and Ireland (BSBI).
• Gentianella amarella (L.) Börner — Ethnobotanical notes. BSBI Fermanagh.
• Gentianella amarella — Felwort, Autumn dwarf gentian. Plants For A Future (PFAF) Database.
• Gentians — A Modern Herbal. Botanical.com (M. Grieve).
• Gentian (Gentiana lutea): Benefits, Safety, Uses. Herbal Reality.
• Bach Original Flower Remedies — Gentianella amarella whole solution. DailyMed / NIH NLM.
• Mudrić J et al. Phytochemical Analysis, Antioxidant, and Antineurodegenerative Properties of Gentiana lutea Root Extract. Natural Product Communications. SAGE. 2025.
• Isolation and HPLC Determination of the Chemical Components of Gentianella acuta. Bentham Science.
• Rubio-Guevara S et al. The ethnobotany and ethnopharmacology of Gentianella alborosea and Gentianella nitida used in Peru. Ethnobotany Research and Applications. 2020.